Kamhawy Adel, Nagy AbdelRahman A, Sallam Emad M
Vascular and Endovascular Surgery Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
J Vasc Access. 2024 Oct 6:11297298241286203. doi: 10.1177/11297298241286203.
When indicated, tunneled hemodialysis catheters are usually inserted using the standard technique but, this technique has its complications. The halfway method is performed by exchange of an already-inserted dialysis catheter (tunneled or non-tunneled) to a tunneled one over a guidewire mounted via the old catheter. In this study, we aimed at evaluating the feasibility, safety, and durability of halfway method in comparison to the standard technique (de novo puncture).
This prospective study was conducted during the period from May 2020 till May 2022 and included 87 patients with end-stage renal disease (ESRD) on regular hemodialysis (HD) in need for insertion new tunneled dialysis catheters instead of temporary or malfunctioning tunneled ones. According to the technique of catheter insertion, these patients were divided into two groups: group A (the halfway technique: catheters were exchanged over guidewires under fluoroscopic control; 48 patients) and group B (the standard technique: via de novo ultrasound-guided vein puncture; 39 patients). Instant, delayed complications and 12-months patency rates were reported and analyzed.
The frequency of peri-operative bleeding complications was better in the halfway group with comparable infection rate and late catheter dysfunction results between the two groups. One year patency rates were 87.5% in halfway technique group compared to 79.5% in standard technique group, yet without statistical significance. However, there was a statistically significant shorter operative time in halfway group (15.54 ± 2.6 min vs 26.97 ± 5.6 min, < 0.001).
The halfway technique may be recommended over the standard technique of tunneled catheter insertion due to shorter operative time, lower rate of hematoma formation, with non-inferior 1-year patency rates and comparable technical success and infection rates. The advantage of access sites preservation for future demand makes this technique of great value to this group of ESRD patients.
在有指征时,隧道式血液透析导管通常采用标准技术插入,但该技术存在并发症。中途法是通过将已插入的透析导管(隧道式或非隧道式)经旧导管置入的导丝换成隧道式导管来进行的。在本研究中,我们旨在评估中途法与标准技术(从头穿刺)相比的可行性、安全性和耐用性。
这项前瞻性研究于2020年5月至2022年5月期间进行,纳入了87例终末期肾病(ESRD)患者,这些患者需定期进行血液透析(HD),需要插入新的隧道式透析导管以替代临时或出现故障的隧道式导管。根据导管插入技术,将这些患者分为两组:A组(中途技术组:在透视引导下经导丝更换导管;48例患者)和B组(标准技术组:通过从头超声引导下静脉穿刺;39例患者)。报告并分析即刻、延迟并发症以及12个月的通畅率。
中途组围手术期出血并发症的发生率较低,两组的感染率和晚期导管功能障碍结果相当。中途技术组的一年通畅率为87.5%,标准技术组为79.5%,但无统计学意义。然而,中途组的手术时间在统计学上显著更短(15.54±2.6分钟对26.97±5.6分钟,P<0.0)。
由于手术时间较短、血肿形成率较低、一年通畅率不劣且技术成功率和感染率相当,与隧道式导管插入的标准技术相比,中途技术可能更值得推荐。保留穿刺部位以备未来需求的优势使得该技术对这组ESRD患者具有重要价值。